Table 4.
The percentage of DLQI score >10 and potential influencing factors of the higher DLQI score among psoriasis patients in China, 2020–2021.
| Variables | Percentage of DLQI score >10, n (%) | Model 1 |
Model 2 |
||
|---|---|---|---|---|---|
| OR | 95% CI | OR | 95% CI | ||
| Age (years), median (IQR) | |||||
| <30 | 332 (31.7) | 1.00 | – | 1.00 | – |
| 30–39 | 459 (34.9) | 1.16 | 0.97–1.37 | 1.08 | 0.90–1.29 |
| 40–49 | 246 (33.0) | 1.07 | 0.87–1.30 | 0.93 | 0.75–1.14 |
| ≥50 | 332 (29.7) | 0.91 | 0.76–1.09 | 0.76 | 0.63–0.92 |
| Gender, median (IQR) | |||||
| Male | 912 (33.4) | 1.00 | – | 1.00 | – |
| Female | 457 (30.6) | 0.88 | 0.77–1.01 | 0.97 | 0.83–1.14 |
| BMI (kg/m2), median (IQR) | |||||
| <18.5 (lower body weight) | 46 (25.6) | 1.00 | – | 1.00 | – |
| 18.5–23.9 (normal body weight) | 638 (31.9) | 1.37 | 0.96–1.93 | 1.35 | 0.94–1.94 |
| 24.0–27.9 (overweight) | 435 (32.7) | 1.42 | 1.00–2.02 | 1.35 | 0.93–1.96 |
| ≥28 (obesity) | 250 (34.6) | 1.54 | 1.07–2.23 | 1.47 | 1.01–2.16 |
| Medical insurance, median (IQR) | |||||
| Yes | 25 (21.7) | 1.00 | – | 1.00 | – |
| No | 1344 (32.7) | 1.74 | 1.12–2.73 | 1.76 | 1.12–2.78 |
| PASI score, median (IQR) | |||||
| <3 | 197 (18.9) | 1.00 | – | 1.00 | – |
| 3–7 | 302 (28.2) | 1.68 | 1.37–2.06 | 1.69 | 1.38–2.08 |
| 8–11 | 270 (37.1) | 2.52 | 2.03–3.13 | 2.61 | 2.10–3.25 |
| ≥12 | 600 (43.2) | 3.25 | 2.70–3.93 | 3.36 | 2.78–4.07 |
OR: odds ratio; CI: confidence interval; IQR: interquartile range; PASI: psoriasis severity and severity index; DLQI: Dermatology Life Quality Index.
Model 1: univariate logistic regression; model 2: multivariate logistic regression.